Welcome to our dedicated page for Newhydrogen news (Ticker: NEWH), a resource for investors and traders seeking the latest updates and insights on Newhydrogen stock.
NewHydrogen, Inc. develops ThermoLoop, a thermochemical water-splitting technology designed to use water and heat rather than electricity to produce clean hydrogen. News about NEWH centers on ThermoLoop development, including laboratory demonstrations, pre-pilot technical validation, engineering test-unit work, and commercialization planning for the company’s clean hydrogen process.
Recurring updates also cover NewHydrogen’s collaboration with University of California, Santa Barbara researchers, patent filings for ThermoLoop materials and process improvements, and the use of artificial intelligence and machine learning in materials discovery. Company announcements have also addressed OTCQB trading status and strategic collaboration work evaluating high-temperature heat sources, including advanced nuclear technology, for hydrogen production.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
NewHydrogen, Inc. (OTC:NEWH) has successfully completed the benchmarking of its green hydrogen generator prototype, confirming its performance closely matches existing commercial catalysts. The company, focused on producing low-cost green hydrogen through renewable energy, conducted tests using a five-layer membrane electrode assembly embedded with platinum and iridium catalysts. Following this phase, further evaluations on long-term stability, hydrogen production rate, and overall costs of their novel catalysts will be undertaken. CEO Dr. David Lee expressed optimism about the results, viewing them as a significant step toward enhancing green hydrogen adoption and reducing reliance on rare materials essential for electrolyzers.
NewHydrogen, Inc. (OTC:NEWH) announced the appointment of Steven Hill as Vice President and board member, effective immediately. Hill, with over 20 years in the biopharmaceutical industry, will drive the company’s business development initiatives. His previous roles include positions at AstraZeneca and Relypsa, where he gained substantial sales and marketing experience. NewHydrogen focuses on developing low-cost green hydrogen technology, with a current research program at UCLA aimed at reducing expenses tied to electrolyzers. The company aims to contribute to a $12 trillion green hydrogen market, minimizing the use of costly rare materials in production.